← Leaderboards
Gai Liu
Microbiotix, Inc
$3,152,933
Attributed
$3,925,970
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $977.4K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,925,970 · 6
By mechanism
R43$2,379,896 · 4
R42$977,449 · 1
R41$568,625 · 1
Top collaborators
- Gaya K. Amarasinghe3 shared
Others in their field
Other Emerging Leaders on “Infection”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$207,651,224
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Research focus
InfectionPropertyIn VivoViralProphylacticPharmaceutical PreparationsIn VitroSeriesSmall Molecule InhibitorFda ApprovedMedicalDrug KineticsCytotoxicityDisease OutbreaksVaccinesExhibitsVirus DiseasesSmall MoleculeAntiviral AgentsFamilyStructureBindingVirusCells
Grant awards (11)
Discovery of Bunyaviral Endonuclease Inhibitors for Anti Viral$977,449
R42 · FY2025 · AI · contact PI
Development of antibody drug conjugates as pan-filo antivirals$286,708
R43 · FY2024 · AI · contact PI
Development of antibody drug conjugates as pan-filo antivirals$300,000
R43 · FY2023 · AI · contact PI
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy$272,089
R41 · FY2023 · AI · contact PI
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy$296,536
R41 · FY2022 · AI · contact PI
Discovery of Enterovirus D68 2A protease inhibitors for antiviral therapy$300,000
R43 · FY2021 · AI · contact PI
Discovery of Enterovirus D68 2A protease inhibitors for antiviral therapy$300,000
R43 · FY2020 · AI · contact PI
Novel Small Molecule Therapeutics Inhibiting Zika Virus Infection$297,627
R43 · FY2019 · AI · contact PI
Inhibitors of virus glycoprotein-LAMP1 receptor binding for Lassa virus therapy$296,161
R43 · FY2019 · AI · contact PI
Novel Small Molecule Therapeutics Inhibiting Zika Virus Infection$300,000
R43 · FY2018 · AI · contact PI
Inhibitors of virus glycoprotein-LAMP1 receptor binding for Lassa virus therapy$299,400
R43 · FY2018 · AI · contact PI